50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Centene Corp director Thomas Greco buys $1.02 million in stock

Published 19/12/2024, 23:42
Centene Corp director Thomas Greco buys $1.02 million in stock
CNC
-

Thomas Greco, a director at Centene Corp (NYSE:CNC), recently purchased 17,000 shares of the company’s common stock. This purchase aligns with broader management confidence in the $30 billion healthcare provider, which according to InvestingPro analysis, is currently trading below its Fair Value. The transaction, which took place on December 18, 2024, involved a weighted average price of $59.75 per share. The shares were acquired at prices ranging from $59.68 to $59.76, totaling approximately $1.02 million. Following this purchase, Greco now holds 19,309 shares, including 2,309 shares of restricted stock units subject to vesting requirements. Trading at a P/E ratio of 10.35, with analysts setting price targets up to $93, Centene shows promising valuation metrics. For deeper insights into Centene’s valuation and 8 additional ProTips, explore the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Centene Corporation has been the focus of various analyst adjustments. Baird raised Centene’s price target from $66 to $71, maintaining a neutral rating. This change is based on an estimated earnings per share (EPS) for 2025 of $7.25. Conversely, Jefferies reiterated an underperform rating on Centene shares, maintaining a price target of $52.00. The firm cited concerns over Centene’s focus on the Health Insurance Exchange market and skepticism towards Centene’s Prescription Drug Plan margins.

JPMorgan upgraded Centene to overweight, despite an anticipated decline in EPS due to the expiration of eAPTCs. The firm sees potential for positive outcomes for Centene, particularly if subsidies and Medicaid policies evolve favorably. Truist Securities adjusted Centene’s stock price target to $84, maintaining a buy rating based on the company’s robust long-term targets and solid initial guidance for 2025.

Stephens, however, cut Centene’s stock price target from $75.00 to $73.00, retaining an equal weight rating. The firm noted Centene’s strategic shift towards long-term growth, focusing on earnings potential expected to be realized in the latter half of the decade. These are the recent developments for Centene Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.